Two US healthcare companies have brought new hope in the fight against coronavirus, with Johnson & Johnson announcing a potential vaccine that could be available early next year and Abbott Laboratories launching a rapid test kit.
J&J said on Monday it had identified a vaccine candidate and was teaming up with the US government to invest $1bn in its development, expecting to start testing in humans by September.
Abbott said it was launching a test for the virus that could take as little as five minutes and could be run on a portable machine the size of a toaster.
您已閱讀15%（566字），剩余85%（3300字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。